Cargando…
POS-326 AKI IS A USEFUL PREDICTOR OF POOR OUTCOMES IN COVID-19
Autores principales: | JACKSON, D., Antonius, M., Shiel, M., Davies, H., Aithal, V., Hancock, C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8049731/ http://dx.doi.org/10.1016/j.ekir.2021.03.342 |
Ejemplares similares
-
POS-012 RISK FACTORS FOR AKI AND MORTALITY IN COVID-19 IN WESTERN MEXICO
por: GARCIA RIVERA, A., et al.
Publicado: (2022) -
POS-870 NGAL and microalbuminuria as AKi biomarkers in COVID-19 hospitalized patients with pneumonia
por: Rizo Topete MD, L., et al.
Publicado: (2022) -
POS-206 INCIDENCE AND EARLY PREDICTORS OF AKI IN COVID 19 PATIENTS IN A TERTIARY CARE CENTRE : A RETROSPECTIVE STUDY
por: R, B., et al.
Publicado: (2021) -
POS-027 Critical illness and systemic inflammation are key risk factors of severe AKI in patients with COVID-19
por: HARDENBERG, J.H.B., et al.
Publicado: (2021) -
POS-853 AKI due to COVID-19 disease requiring Renal Replacement Therapy: role of Expanded HaemoDialisys (HDx) on inflammation and outcome
por: Gernone, G., et al.
Publicado: (2022)